A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis

NCT01808157 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: CT327 ointment
DRUG: placebo

Sponsor

Creabilis SA